| 1 |
Robert E. Bridges |
Faro Technologies |
25 |
| 2 |
Andrew P. Combs |
Incyte |
10 |
| 3 |
Robert A. Vito |
Matscitechno Licensing |
4 |
| #4 |
Jeffrey C. Trewella |
ExxonMobil |
3 |
| #4 |
Daniel D. Friel, Jr. |
Edgecraft |
3 |
| #4 |
Argyrios G. Arvanitis |
Incyte |
3 |
| #4 |
Xuehui Sun |
The Chemours Company Fc |
3 |
| #4 |
Christopher J. Bish |
E.I. Du Pont De Nemours And |
3 |
| #9 |
Robert A. Johns |
The Chemours Company Tt |
2 |
| #9 |
Nils P. Steffensen |
Faro Technologies |
2 |
| #11 |
William Frietze |
Incyte |
1 |
| #11 |
Robert Scholz |
RTX (Raytheon) |
1 |
| #11 |
Daniel Friel |
Edgecraft |
1 |
| #11 |
Richard Bauer |
E.I. Du Pont De Nemours And |
1 |
| #11 |
Robert P. Ricciardi |
University of Pennsylvania |
1 |
| #11 |
Perry G. Caimi |
E.I. Du Pont De Nemours And |
1 |
| #11 |
Sandra Fowkes Godek |
— |
1 |
| #11 |
David Thompson |
Siemens Healthcare Diagnostics |
1 |
| #11 |
Robert Houghtaling |
Columbia University |
1 |
| #11 |
Daniel J. Mockler |
Faro Technologies |
1 |
| #11 |
Vivek Kapur |
E.I. Du Pont De Nemours And |
1 |
| #11 |
Jeffrey H. Peltier |
Betzdearborn |
1 |
| #11 |
Christopher Mark Pepe |
— |
1 |
| #11 |
Tina Sanders Pragoff |
JPMorgan Chase |
1 |
| #11 |
Sherry Ann Allen |
JPMorgan Chase |
1 |
| #11 |
Hong Wang |
Nps Pharmaceuticals |
1 |
| #11 |
George K. Kodokian |
E.I. Du Pont De Nemours And |
1 |
| #11 |
Melanie K. Tallent |
Drexel University |
1 |
| #11 |
Gordon J. Lutz |
Drexel University |
1 |
| #11 |
Andrew Delano Odell |
Constellation Energy Generation |
1 |
| #11 |
David T. Beatson |
Kulicke & Soffa Investments |
1 |
| #11 |
Margaret K. Oplinger |
Hercules |
1 |
| #11 |
Gregory M. Acland |
Cornell Research Foundation |
1 |